JPRN-UMIN000034193
Recruiting
N/A
Evaluation of blood flow of malignant tumor using O-15 water PET: the effect of blood flow on therapeutic response - Evaluation of blood flow of malignant tumor using O-15 water PET
Conditionsung cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- ung cancer
- Sponsor
- Osaka University Graduate School of Medicine
- Enrollment
- 24
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients who are assumed to be difficult to implement this PET examination due to general condition etc. 2\) Women who are pregnant 3\) Other patients who are judged inappropriate by research researcher, etc.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Evaluation of the tumor blood flow by computed tomography(CT)perfusion imaging and an effect of chemotherapy or radiotherapy for esophageal canceresophageal cancerJPRN-UMIN000015597Tohoku University Graduate School of Medicine50
Recruiting
N/A
Evaluation of organ and tumour perfusion by contrast-enhanced ultrasound after transarterial chemoembolization because hepatocellular carcinomaC22.0Liver cell carcinomaDRKS00016987niversitätsklinikum FrankfurtMedizinische Klinik 1174
Completed
N/A
ateral Flow Assay for Detection of Through Tumor Necrosis Factor Alpha (Infliximab) levelsNL-OMON32551niversitair Medisch Centrum40
Recruiting
N/A
Characterization of circulating tumour cells undergoing epithelial-mesenchymal transition in hepatocellular carcinoma and its revlevance in tumor staging modalitiesHepatocellular carcinomaCirculating tumor cells, Hepatocellular carcinoma, Epithelial-mesenchymal transition, Phenotype, prognosisTCTR20220613008Faculty of Medicine, Chiang Mai University44
Active, Not Recruiting
Phase 1
Assessment of the effect of a chemotherapy combining two molecules administred before surgery in patients with pancreas cancerPotentially resectable pancreatic ductal adenocarcinomaTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-003516-31-BECUB Erasme Hospital